Legend Biotech CFO Carlos Santos sells $49,630 in shares

Legend Biotech Corp.'s CFO, Carlos Santos, recently sold 5,430 ordinary shares worth around $49,630, according to an SEC filing from September 21, 2026. The sale occurred in shares priced between $8.905 and $9.325, with a weighted average price of $9.14 per share. Currently trading at $18.45, the stock has increased by nearly 10% over the past week, although it has declined 14% year-to-date.

Legend Biotech appears undervalued and holds more cash than debt on its balance sheet. Santos' sale was to satisfy withholding tax obligations after the vesting of restricted share units. The following day, he purchased an additional 19,676 ordinary shares, valued at $0. Notably, the company's ordinary shares may be represented by American Depositary Shares, with each ADS representing two ordinary shares.